The strong correlation of GHD with the presence of HD found in our population of polytransfused patients should prompt clinical investigators to examine the endocrinological influence and especially the GH-IGF-1 axis abnormalities, on altered heart function and impaired ventricular contractility in such patients, and to analyze the effect of GH replacement therapy on cardiac performance. This evidence concerns the gene IGF1 and Huntington disease.